
Welgrel 75mg Tablet
Marketer
Welkind Pharma
Salt Composition
Clopidogrel (75mg)
Overview Welgrel 75mg Tablet
Cardiogard 75mg tablets are antithrombotic agents, preventing the formation of dangerous blood clots within your circulatory system. This significantly reduces the risk of stroke or myocardial infarction. Widely prescribed for cardiovascular protection, Cardiogard 75mg is indicated for patients with elevated heart disease risk. This includes individuals with peripheral arterial disease (circulatory issues stemming from vascular narrowing), recent stroke or heart attack, arrhythmias, and those who have undergone procedures like coronary stent placement. It's also used adjunctively with other medications to manage myocardial infarction and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continued use is crucial, even in the absence of symptoms, as cessation increases the risk of stroke or heart attack. The most frequently reported adverse event is hemorrhage, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier than normal menstrual bleeding. Wounds may exhibit prolonged bleeding. While usually mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in patients with active internal bleeding, such as gastrointestinal ulcers or intracranial hemorrhage. Prior to initiating treatment, inform your physician of any existing bleeding disorders or recent significant trauma or surgery. Temporary discontinuation may be necessary before scheduled surgical or dental procedures.
Uses of Welgrel 75mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Welgrel 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg Welgrel tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Welgrel 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Welgrel 75mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Welgrel 75mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Welgrel 75mg Tablet works:
Plavix 75mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous clot formation and consequently lowering the likelihood of cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Welgrel 75mg Tablets requires careful consideration. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Welgrel 75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Welgrel 75mg tablets appear compatible. Available human data indicates minimal infant risk associated with this medication.
DrivingSAFE
Driving ability is typically unaffected by Welgrel 75mg Tablets.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Welgrel 75mg tablets without requiring a dosage modification.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely take Welgrel 75mg tablets without requiring a dosage change.
What if you forget to take Welgrel 75mg Tablet :
Should you forget a Welgrel 75mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Welgrel 75mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
